GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

MedMira MIR.V · CAD

Health Care · TSX Venture · 🇨🇦 Canada

Compare

0.05

0.00%

Close of 6 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

MedMira — daily TSXV:MIR Delayed
Market value
C$35.1m
Last close × shares
Volume
11.4k
Shares, 6 Nov 2026

About MedMira

Its shares trade on TSX Venture under the ticker MIR.V. It has been listed since 1 December 1999. In the fiscal year to 31 July 2025, it reported revenue of C$240,509 and a net loss of C$4.5m. At that date it held total assets of C$3.7m and shareholders' equity of −C$22.6m.

MedMira, Inc. is a biotechnology company, which through its subsidiaries, engages in the research, development, manufacture, and commercialization of diagnostics and technology platforms. The company is headquartered in Halifax, Nova Scotia. The firm is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The firm operates through the rapid diagnostic products and services segment. The Rapid Vertical Flow (RVF) Technology platform is the basis for the Company's line of rapid tests. Its research focuses on specific areas of the diagnostics market, such as rapid, point-of-care and in vitro sectors. The RVF technology platform includes a three component system: a test cartridge, multi-function buffer and InstantGold Cap. Its technology can be applied in healthcare, research and industrial markets. The company offers rapid tests for testing serum, plasma or whole blood specimens. The firm's tests are sold under brands, including Reveal, Multiplo and Miriad. The firm offers rapid tests for human immunodeficiency virus (HIV), Hepatitis B and C, and syphilis.

Figures and description from our data supplier, not checked against the company's own report.

More about MedMira →

Latest on MedMira

Our reporting

We have not reported on MedMira yet.

Next results

27 Nov 2026

Due on 27 Nov 2026.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is MedMira's ticker?

MedMira trades as MIR.V on TSX Venture, under ISIN CA58501R1029.

What was MedMira's last closing price?

0.05 on 6 Nov 2026. The figure is in CAD and is never converted.

When does MedMira next report results?

Results are expected on 27 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.